Evonik swings axe at API plant
December 18, 2012Manufacturing and Production API, Evonik, cuts, lilly
Fine chemicals company Evonik Degussa has announced job cuts as part of an efficiency drive at a US plant making …
David Haslam confirmed as NICE chair
December 18, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Haslam, Hunt, NICE
David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …
Hospira downgraded as it recalls more sterile injectables
December 18, 2012Manufacturing and Production FDA, Hospira
Generic pharma company Hospira’s efforts to bring its manufacturing network back into compliance took a knock this week when it …
Perjeta recommended in EU
December 18, 2012Sales and Marketing CHMP, Cancer, Perjeta, Roche
Roche’s breast cancer treatment Perjeta has been given the thumbs up by the CHMP, paving the way for its approval …
SHL’s 2012 Winter Toy & Book Drive
December 18, 2012Manufacturing and Production shl csr, shl green, shl group, shl world vision
As a continuing effort to give back to society, this year SHL organized a Winter Toy & Book Drive, collecting …
US bill grants incentives to scarce drug producers
December 17, 2012Manufacturing and Production FDA, PADSA
New legislation tabled in the US could provide incentives to companies producing drugs that are in short supply – particularly …
Teva revamp will see manufacturing shake-up
December 17, 2012Manufacturing and Production Levin, Teva, manufacturing
Teva’s recent announcement of a major restructuring of its business to cut costs and maintain profitability includes a revamp of …
CHMP turns down Kynamro
December 17, 2012Sales and Marketing CHMP, Genzyme, Kynamro, Sanofi
Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …
Signifor approved in US
December 17, 2012Sales and Marketing Cushing's, Novartis, Signifor
Novartis’ injection Signifor has been approved by the FDA to treat Cushing’s disease, a rare but serious endocrine disorder affecting …
Swiss Re helps Roche open up China’s oncology market
December 17, 2012Sales and Marketing Cancer, China, Roche, Swiss re, oncology
Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …
Amgen appoints Mattel’s Robert Eckert to Board of directors
December 14, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Eckert
Biotech firm Amgen has announced the appointment of Robert Eckert, former chief executive officer at Mattel, to its Board of …
RA setbacks for AstraZeneca and Lilly
December 14, 2012Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly
AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …
Revlimid patient scheme ‘working’
December 14, 2012Sales and Marketing Celgene, Revlimid
Celgene has issued figures which it says demonstrate the clinical value of the NICE-agreed patient access scheme for its cancer …
David Stack appointed to Amarin Board of directors
December 14, 2012Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack
Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of …
Board consults on specialised services
December 13, 2012Sales and Marketing CF, NHS CB, Sickle cell
The NHS Commissioning Board has launched a consultation into how the NHS provides specialised services, including treatments for conditions such …
‘Augmented reflection’ brings GAD to life
December 13, 2012Medical Communications GAD, Pfizer, You Tube
Pfizer has worked with patient group Anxiety UK to create a new ‘enhanced reflection’ video to raise awareness of Generalised …
Hold tight: a bumpy ride ahead for the NHS
December 13, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hunt, Lansley, NHS, Wallards, reforms
The Wellards Annual Conference is an event where two worlds – the industry and the NHS – meet for a …
Stevenage Bioscience Catalyst hires first entrepreneur-in-residence
December 13, 2012Manufacturing and Production, Research and Development, Sales and Marketing Stevenage Bioscience Catalyst
Early-stage biotech firm Stevenage Bioscience Catalyst (SBC) has appointed Dr Barbara Domayne-Hayman as its first entrepreneur-in-residence. Domayne-Hayman will work with …
Eliquis in UK for AF
December 13, 2012Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer
Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …
New managing director for Lilly UK
December 12, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly
Lilly UK has appointed Dr Jean-Michel Cosséry as the new managing director and VP of the UK Affiliate and the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
